Endoxan and acute myeloid leukaemia Patient Reports February 12, 2012



Endoxan Side Effects Report #6010150-4
Endoxan side effect was reported by a Health Professional from FRANCE on Dec 15, 2008. Female patient, 81 years of age, weighting 123.5 lb, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, infection What is  infection, lung disorder. Endoxan dosage: unknown. During the same period patient was treated with ENDOXAN BAXTER, MABTHERA, FLUDARABINE PHOSPHATE, CHLORAMBUCIL. Patient recovered.

Endoxan Side Effects Report #4952947-5
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2006. Male patient, 62 years of age, was diagnosed with stem cell transplant, diffuse large b-cell lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN, CYTARABINE, ADRIACIN, ONCOVIN, CYMERIN. Patient died on 09/08/2000.

Endoxan Side Effects Report #4952948-7
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 15, 2006. Male patient, 36 years of age, was diagnosed with stem cell transplant, diffuse large b-cell lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN, CYTARABINE, ADRIACIN, ONCOVIN, CYMERIN. Patient died on 01/15/2004.

Endoxan Side Effects Report #5134887-4
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 16, 2006. Female patient, 56 years of age, was diagnosed with ovarian cancer and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia. Endoxan dosage: unknown. During the same period patient was treated with ETOPOSIDE, EPIRUBICIN, CISPLATIN, PACLITAXEL, CARBOPLATIN, TAXOTERE. Patient died.


Endoxan Side Effects Report #5469379-6
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 20, 2007. Male patient, 65 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia. Endoxan dosage: unknown. During the same period patient was treated with RITUXAN, ADRIAMYCIN PFS, VINCRISTINE, CORTANCYL. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #4548533-1
Endoxan side effect was reported by a Health Professional from on Dec 30, 2004. Female patient, 57 years of age, weighting 136.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with HOLOXAN, BLEOMYCIN SULPHATE, ETOPOSIDE DAKOTA PHARM, ADRIBLASTINE, ARACYTINE, METHOTREXATE, ELDISINE. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #4564533-X
Endoxan side effect was reported by a Health Professional from on Dec 30, 2004. Female patient, 57 years of age, weighting 136.7 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, infection What is  infection, inflammation, tracheal disorder, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with HOLOXAN, BLEOMYCIN, ETOPOSIDE, ADRIBLASTINE, ARACYTINE, METHOTREXATE, ELDISINE. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #5574226-8
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 18, 2007. Female patient, 61 years of age, was diagnosed with multiple sclerosis What is  multiple sclerosis and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia. Endoxan dosage: unknown. During the same period patient was treated with METHOTREXATE, BETASERON, NOVANTRONE. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #5507430-5
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 29, 2007. Male patient, 69 years of age, was diagnosed with mantle cell lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia. Endoxan dosage: unknown. During the same period patient was treated with ETOPOSIDE, BICNU, ARACYTINE, ALKERAN, MABTHERA, ADRIAMYCIN PFS. Patient was hospitalized. Patient recovered.


Endoxan Side Effects Report #5716360-5
Endoxan side effect was reported by a Consumer or non-health professional from FRANCE on Apr 23, 2008. Male patient, 69 years of age, was diagnosed with mantle cell lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia. Endoxan dosage: unknown. During the same period patient was treated with ETOPOSIDE, BICNU PWDR, ARACYTINE, ALKERAN, MABTHERA, ADRIAMYCIN PFS. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #5519234-8
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 05, 2007. Male patient, 61 years of age, was diagnosed with lymphoma What is  lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia. Endoxan dosage: unknown. During the same period patient was treated with METHOTREXATE, ADRIBLASTINE, VELBE, BLEOMYCIN, PREDNISOLONE. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #5582706-4
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 28, 2007. Female patient, child 11 years of age, was diagnosed with lymphoma What is  lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia. Endoxan dosage: unknown. During the same period patient was treated with DOXORUBICIN, EPIRUBICIN. Patient recovered.

Endoxan Side Effects Report #5577958-0
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 22, 2007. Female patient was diagnosed with lymphoma What is  lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia. Endoxan dosage: unknown. During the same period patient was treated with ETOPOSIDE, DOXORUBICIN, EPIRUBICIN. Patient recovered.

Endoxan Side Effects Report #4548528-8
Endoxan side effect was reported by a Health Professional from on Dec 30, 2004. Male patient, 39 years of age, was diagnosed with hodgkin's disease nodular sclerosis stage iii and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with BLEOMYCIN SULPHATE, DOXORUBICIN, NATULAN, ETOPOSIDE DAKOTA PHARM, VINCRISTINE. Patient was hospitalized. Patient recovered.


Endoxan Side Effects Report #5750595-0
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on May 20, 2008. Female patient, 58 years of age, was diagnosed with burkitt's lymphoma, acute lymphocytic leukaemia and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, acute respiratory distress syndrome, febrile bone marrow aplasia, left ventricular failure, sepsis What is  sepsis, stomatitis. Endoxan dosage: unknown. During the same period patient was treated with DOXORUBICIN, ONCOVIN, METHOTREXATE, PREDNISOLONE. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #5876425-4
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 01, 2008. Female patient, 58 years of age, was diagnosed with burkitt's lymphoma, acute lymphocytic leukaemia and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, acute respiratory distress syndrome, febrile bone marrow aplasia, left ventricular failure, sepsis What is  sepsis, stomatitis. Endoxan dosage: unknown. During the same period patient was treated with DOXORUBICIN, ONCOVIN, METHOTREXATE, PREDNISOLONE. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #5577685-X
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 22, 2007. Male patient, child 4 years of age, was diagnosed with burkitt's lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia. Endoxan dosage: unknown. During the same period patient was treated with ETOPOSIDE, EPIRUBICIN. Patient died.

Endoxan Side Effects Report #5582789-1
Endoxan side effect was reported by a Physician from UNITED STATES on Dec 28, 2007. Male patient, child 4 years of age, was diagnosed with burkitt's lymphoma, bone marrow conditioning regimen and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia. Endoxan dosage: 1 FORM = 9 G/M2; 60MG/M2 ADMINISTERED FOR BONE MARROW CONDITIONG.. During the same period patient was treated with ETOPOSIDE, EPIRUBICIN, MITOXANTRONE, IDARUBICIN. Patient died.

Endoxan Side Effects Report #4546089-0
Endoxan side effect was reported by a Health Professional from on Dec 29, 2004. Female patient, 68 years of age, was diagnosed with breast cancer What is  breast cancer and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acinetobacter infection, acute myeloid leukaemia, acute respiratory distress syndrome, agranulocytosis, respiratory tract infection, treatment related secondary malignancy. Endoxan dosage: unknown. During the same period patient was treated with NOVANTRONE. Patient died on 09/21/2003.


Endoxan Side Effects Report #5908321-8
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 25, 2008. Female patient, 67 years of age, was diagnosed with breast cancer What is  breast cancer and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia. Endoxan dosage: unknown. During the same period patient was treated with EPIRUBICIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #5134700-5
Endoxan side effect was reported by a Consumer or non-health professional from FRANCE on Oct 13, 2006. Female patient, 62 years of age, was diagnosed with breast cancer What is  breast cancer, breast cancer stage iii and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, pancytopenia. Endoxan dosage: unknown. During the same period patient was treated with TAXOL, NAVELBINE, HERCEPTIN, ADRIAMYCIN PFS. Patient recovered.

Endoxan Side Effects Report #5638240-6
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 14, 2008. Female patient, 62 years of age, was diagnosed with breast cancer What is  breast cancer and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia. Endoxan dosage: unknown. During the same period patient was treated with FARMORUBICIN, FLUOROURACIL. Patient died on 11/14/2005.

Endoxan Side Effects Report #5825060-2
Endoxan side effect was reported by a Health Professional from GERMANY on July 25, 2008. Female patient, 59 years of age, was diagnosed with breast cancer What is  breast cancer and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia. Endoxan dosage: unknown. During the same period patient was treated with TAXOL, EPIRUBICIN. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #5856644-3
Endoxan side effect was reported by a Health Professional from GERMANY on Aug 22, 2008. Female patient, 59 years of age, was diagnosed with breast cancer What is  breast cancer, leukopenia and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia. Endoxan dosage: unknown. During the same period patient was treated with TAXOL, EPIRUBICIN, NEULASTA, ARIMIDEX, LEVOTHYROXINE, DARBEPOETIN ALFA. Patient was hospitalized. Patient recovered.


Endoxan Side Effects Report #4548161-8
Endoxan side effect was reported by a Health Professional from on Dec 30, 2004. Female patient, 26 years of age, weighting 99.21 lb, was diagnosed with b-cell lymphoma and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, pancytopenia, treatment related secondary malignancy, unevaluable event. Endoxan dosage: 1300 MG DAY 1 AND DAY 2 (C1: 29-DEC, C-2: 13-JAN, C;3 28-JAN-2003) 100 MG 13-FEB-2003 (C4). During the same period patient was treated with IFOSFAMIDE, ADRIBLASTIN, ETOPOSIDE DAKOTA PHARM, MABTHERA, METHOTREXATE. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #5263559-0
Endoxan side effect was reported by a Health Professional from UNITED STATES on Mar 01, 2007. Male patient, 64 years of age, was diagnosed with adult t-cell lymphoma/leukaemia and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia. Endoxan dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DOXORUBICIN, ETOPOSIDE, CARBOPLATIN, METHOTREXATE, VINDESINE SULPHATE, PREDNISOLONE, RANIMUSTINE. Patient recovered.

Endoxan Side Effects Report #5263698-4
Endoxan side effect was reported by a Health Professional from UNITED STATES on Mar 01, 2007. Male patient, 64 years of age, was diagnosed with adult t-cell lymphoma/leukaemia, prophylaxis and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia. Endoxan dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DOXORUBICIN, ETOPOSIDE, CARBOPLATIN, METHOTREXATE, VINDESINE SULPHATE, PREDNISOLONE, RANIMUSTINE. Patient recovered.

Endoxan Side Effects Report #5268234-4
Endoxan side effect was reported by a Health Professional from UNITED STATES on Mar 16, 2007. Male patient, 64 years of age, was diagnosed with adult t-cell lymphoma/leukaemia, prophylaxis and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia. Endoxan dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DOXORUBICIN, ETOPOSIDE, CARBOPLATIN, METHOTREXATE, VINDESINE SULPHATE, PREDNISOLONE, RANIMUSTINE. Patient recovered.

Endoxan Side Effects Report #5263536-X
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 01, 2007. Female patient, 63 years of age, was diagnosed with adult t-cell lymphoma/leukaemia, prophylaxis and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression. Endoxan dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DOXORUBICIN, ETOPOSIDE, CARBOPLATIN, METHOTREXATE, PREDNISOLONE, RANIMUSTINE, VINDESINE SULPHATE. Patient died on 12/01/2005.


Endoxan Side Effects Report #5267561-4
Endoxan side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 16, 2007. Female patient, 63 years of age, was diagnosed with adult t-cell lymphoma/leukaemia, prophylaxis and was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, malignant neoplasm progression. Endoxan dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DOXORUBICIN, ETOPOSIDE, CARBOPLATIN, METHOTREXATE, PREDNISOLONE, RANIMUSTINE, VINDESINE SULPHATE. Patient died on 12/01/2005.

Endoxan Side Effects Report #4548158-8
Endoxan side effect was reported by a Health Professional from on Dec 30, 2004. Male patient, 25 years of age, weighting 141.1 lb, was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, treatment related secondary malignancy. Endoxan dosage: CY. 1-4 = 2400MG, CY 4-8 = 1100 MG (DAY 1). During the same period patient was treated with BLEOMYCIN SULPHATE, ADRIBLASTINE, NATULAN, ETOPOSIDE DAKOTA PHARM, VINCRISTINE. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #4554217-6
Endoxan side effect was reported by a Health Professional from on Dec 30, 2004. Male patient, 25 years of age, weighting 141.1 lb, was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, treatment related secondary malignancy. Endoxan dosage: CY. 1-4 = 2400MG, CY 4-8 = 1100 MG (DAY 1). During the same period patient was treated with BLEOMYCIN, ADRIBLASTINE, NATULAN, ETOPOSIDE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #4563622-3
Endoxan side effect was reported by a Health Professional from on Dec 30, 2004. Male patient, 25 years of age, weighting 141.1 lb, was treated with Endoxan. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, treatment related secondary malignancy. Endoxan dosage: CY. 1-4 = 2400MG, CY 4-8 = 1100 MG (DAY 1). During the same period patient was treated with BLEOMYCIN SULPHATE, ADRIBLASTINE, NATULAN, ETOPOSIDE, VINCRISTINE. Patient was hospitalized. Patient recovered.
SideEffects101.com does not provide medical advice, diagnosis or treatment. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting SideEffects101.com and reading about

side effects of Endoxan